1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
  1. Launch

Cartilago Srl

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Location

Lecce Italy

Primary Industry

Biotechnology

About

Based in Lecce, Italy, Cartilago Srl operates as a biotechnology company that harnesses regenerative medicine to develop disease-modifying, chondroprotective technologies for combatting osteoarthritis and related pathologies. In July 2020, Cartilago Srl raised seed funding from CDP Venture Capital. The company offers advanced solutions in regenerative medicine to develop disease-modifying, chondroprotective technologies for combatting osteoarthritis and related pathologies. It uses technologies that are being used for anti-aging solutions, wound care, and anti-metastatic therapies for cancer and for addressing additional indications.
Current Investors
CDP Venture Capital

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biotechnology, Diagnostic, Medical & Imaging Laboratories, Monitoring Equipment
Website
www.cartilago.it
Verticals
Research (Non-Medical)
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.